Tag: Boehringer Ingelheim / A*STAR
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative...
Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapiesThese engineered antibodies...